The interface of Medicare coverage decision-making and emerging molecular-based laboratory testing

Area of Science:

• Laboratory Medicine
• Health Policy
• Molecular Diagnostics

Background:

• Medicare coverage determination for clinical services is complex, causing confusion.
• Molecular diagnostic testing presents unique challenges for providers and payers.
• Defining medical necessity for novel tests is an evolving process.

Purpose of the Study:

• To clarify Medicare's medical necessity definition process for coverage.
• To describe national and local Medicare coverage policy procedures.
• To highlight the evolving nature of Medicare reimbursement for esoteric testing.

Main Methods:

• Review of Medicare coverage policy processes at national and local levels.
• Analysis of challenges in molecular diagnostic test reimbursement.
• Inclusion of case study vignettes to illustrate payer engagement.

Main Results:

• Medicare coverage policy processes are complex and not fully established for novel molecular tests.
• Reimbursement for esoteric testing is a work-in-progress.
• Stakeholders can engage payers to develop sound coverage policies.

Conclusions:

• Understanding Medicare's coverage policies is crucial for molecular diagnostics.
• Collaboration between laboratorians, clinicians, and payers is essential.
• Developing medically sound and fiscally responsible coverage policies is an ongoing opportunity.